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Summary
Background.  —  Postoperative  atrial  ﬁbrillation  (POAF)  is  a  common  complication  after  car-
diac surgery,  with  increased  risk  of  embolic  events,  haemodynamic  instability,  haemorrhagic
complications  and  prolonged  hospital  stay.
Abbreviations: AF, atrial ﬁbrillation; AUC, area under curve; AVR, aortic valve replacement; CABG, coronary artery bypass graft; COPD,
chronic obstructive pulmonary disease; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; POAF, postoperative atrial
ﬁbrillation; ROC, receiver operating characteristic.
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Aims.  —  We  sought  to  assess  the  value  of  preoperative  left  ventricular  global  longitudinal  strain
(GLS) for  the  prediction  of  POAF  in  a  series  of  patients  with  severe  symptomatic  aortic  stenosis
who underwent  aortic  valve  replacement  (AVR).
Methods.  —  Fifty-eight  consecutive  patients  (52%  men)  aged  73  ±  9  years,  with  severe  symp-
tomatic aortic  stenosis  (aortic  valve  area  <  1  cm2 or  <  0.5  cm2/m2),  in  sinus  rhythm,  who
underwent  AVR  were  prospectively  included  in  three  centres  between  2009  and  2010.  Complete
preoperative  echocardiography  was  performed  in  all  patients,  including  global  and  segmental
longitudinal  strain  using  two-dimensional  speckle  tracking.
Results.  —  The  POAF  incidence  was  28/58  (48%).  On  univariate  analysis,  aortic  valve  area
(P =  0.04),  preoperative  E/e’  ratio  (P  =  0.04)  and  GLS  (P  =  0.005)  were  associated  with  the  occur-
rence of  POAF.  Chronic  obstructive  pulmonary  disease  (P  =  0.05),  preoperative  statin  treatment
(P =  0.09),  age  ≥  80  years  (P  =  0.09),  left  ventricular  ejection  fraction  (P  =  0.09)  and  systolic  pul-
monary artery  pressure  (P  =  0.06)  tended  to  increase  the  risk  of  POAF.  The  best  GLS  cut-off  value
for the  prediction  of  POAF  was  —15%  (82%  sensitivity,  53%  speciﬁcity,  area  under  the  curve  0.72).
On multivariable  analysis,  GLS  >  —15%  was  the  only  independent  predictor  of  POAF  (odds  ratio
7.74, 95%  conﬁdence  interval  [1.15—52.03];  P  =  0.035).
Conclusions.  —  Incidence  of  POAF  is  high  after  AVR  for  severe  aortic  stenosis.  Our  results  suggest
an additive  value  of  the  study  of  left  ventricular  myocardial  deformation  to  classical  clinical
and echocardiographic  variables  for  the  prediction  of  POAF  in  this  setting.
© 2012  Published  by  Elsevier  Masson  SAS.
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Résumé
Contexte.  — La  ﬁbrillation  atriale  postopératoire  (FAPO)  est  une  complication  courante  après
chirurgie cardiaque,  augmentant  le  risque  d’épisodes  emboliques,  hémorragiques,  d’instabilité
hémodynamique,  prolongeant  l’hospitalisation.
Objectifs.  — Évaluer  l’apport  de  l’étude  de  la  déformation  longitudinale  du  ventricule  gauche  en
utilisant l’imagerie  bidimensionnelle  (strain  global  longitudinal  [SGL])  pour  prédire  la  survenue
de la  FAPO  après  remplacement  valvulaire  aortique  (RVA)  pour  rétrécissement  aortique  serré
(RAC) symptomatique.
Méthodes.  —  Cinquante-huit  patients  consécutifs  (52  %  d’hommes),  âgés  de  73  ±  9  ans,  porteurs
d’un RAC  serré  symptomatique  (déﬁni  par  une  surface  aortique  <  1  cm2 ou  <  0,5  cm2/m2),  en
rythme sinusal,  et  opérés  d’un  RVA  ont  été  inclus  prospectivement  dans  trois  centres  entre
2009 and  2010.  Une  échocardiographie  complète  incluant  le  SGL  a  été  realisée  avant  chirurgie
chez tous  les  patients.
Résultats.  —  L’incidence  de  la  FAPO  était  de  28/58  (48  %).  En  analyse  univariée,  la  surface
aortique  (p  =  0,04),  le  rapport  E/e’  préopératoire  (p  =  0,04)  et  le  SGL  (p  =  0,005)  étaient  associés
à la  survenue  de  FAPO.  La  bronchopathie  obstructive  chronique  (p  =  0,05),  le  traitement  par
statine en  préopératoire  (p  =  0,09),  l’âge  ≥  80  ans  (p  =  0,09),  la  fraction  d’éjection  ventriculaire
gauche (p  =  0,09)  et  la  pression  artérielle  pulmonaire  systolique  (p  =  0,06)  tendaient  vers  la
signiﬁcativité  pour  prédire  la  FAPO.  Le  meilleur  seuil  de  SGL  pour  prédire  la  FAPO  était  de  —15  %
(82 %  de  sensitivité,  53  %  de  spéciﬁcité,  aire  sous  la  courbe  0,72).  En  l’analyse  multivariée,  le
SGL supérieur  à  —15  %  était  le  seul  prédicteur  indépendant  de  FAPO  (OR  7,74  [1,15—52,03],
p =  0,035).
Conclusions.  —  La  FAPO  est  fréquente  après  RVA  pour  RAC  serré.  Nos  résultats  suggèrent  une
valeur additionnelle  de  l’étude  de  la  déformation  longitudinale  du  ventricule  gauche  par
imagerie échographique  bidimensionnelle  aux  paramètres  cliniques  et  échographiques  clas-
siques pour  prédire  la  FAPO.
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ostoperative  atrial  ﬁbrillation  (POAF)  is  a  common
omplication  after  cardiac  surgery.  It  is  associated  with
ncreased  risk  of  embolic  events,  haemodynamic  instabil-
ty,  heart  failure  and  haemorrhagic  complications,  and  it
ften  prolongs  the  duration  of  hospital  stay.  The  inci-
ence  of  POAF  after  valvular  surgery  is  high,  ranging
rom  33%  to  49%  [1].  In  severe  aortic  stenosis,  chronic
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eft  ventricular  pressure  overload  induces  left  ventricular
ypertrophy  that  leads  to  adequate  wall  stress  and  nor-
al  left  ventricular  ejection  fraction  (LVEF).  Nevertheless,
ecent  studies  conducted  in  patients  with  severe  aortic
tenosis  and  normal  LVEF  have  demonstrated,  in  a  signiﬁcant
umber  of  cases,  abnormal  global  myocardial  deforma-
ion  —  particularly  impaired  longitudinal  contraction  [2,3].
hus,  left  ventricular  hypertrophy  induces  both  systolic
nd  diastolic  dysfunction,  leading  to  progressive  left  atrial
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dilatation  and  atrial  ﬁbrillation  (AF).  Therefore,  in  the
present  study  conducted  in  a  series  of  patients  with  severe
symptomatic  aortic  stenosis,  we  sought  to  assess  the  value
of  left  ventricular  global  longitudinal  strain  (GLS)  for  the
prediction  of  POAF  after  aortic  valve  replacement  (AVR).
Methods
Study population
Fifty-eight  consecutive  patients  (30  men,  52%)  aged  73  ±  9
years,  in  sinus  rhythm  at  inclusion,  with  severe  symp-
tomatic  isolated  aortic  stenosis  (aortic  valve  area  <  1  cm2 or
indexed  aortic  valve  area  <  0.5  cm2/m2)  who  underwent  AVR
were  prospectively  included  in  three  centres  (Amiens,  Lille
and  Compiègne).  The  study  was  approved  by  local  review
boards  and  informed  consent  was  obtained  from  the  patients
before  all  procedures.  Exclusion  criteria  were:  severe  co-
morbidities  precluding  AVR  surgery;  more  than  mild  aortic  or
mitral  regurgitation;  and  permanent  AF.  All  patients  under-
went  preoperative  coronary  angiography.  Reduction  of  the
normal  diameter  by  ≥  50%  was  considered  to  deﬁne  signif-
icant  coronary  artery  stenosis  in  the  left  main  coronary
artery.  A  cut-off  value  of  70%  was  used  for  the  right  coronary,
left  anterior  descending  and  circumﬂex  arteries.  Multivessel
coronary  artery  disease  was  deﬁned  as  signiﬁcant  stenoses
in  two  or  more  vessels.
Deﬁnition of atrial ﬁbrillation
During  the  stay  in  the  intensive  care  unit,  the  electrocar-
diogram  was  continuously  monitored  and  recorded.  During
the  entire  hospital  stay,  12-lead  electrocardiograms  were
performed  daily  until  discharge  and  if  requested  by  the
physician  or  in  case  of  symptoms.  POAF  combined  parox-
ysmal  and  persistent  AF.  Paroxysmal  AF  was  deﬁned  as
self-terminating  AF,  usually  within  48  hours  [4].  Persistent
AF  was  deﬁned  as  an  AF  episode  that  lasted  longer  than  7
days  or  required  termination  by  cardioversion  [4].
Echocardiography
Echocardiographic  examinations  were  performed  using  com-
mercially  available  ultrasound  machines  (Vivid  7  and  Vivid
e9;  GE  Healthcare,  Norway).  All  echocardiographic  and
Doppler  data  were  obtained  in  digital  format  and  stored
for  off-line  analysis.  Left  ventricular  and  left  atrial  dimen-
sions  were  measured  according  to  the  American  Society
of  Echocardiography  and  European  Association  of  Echocar-
diography  guidelines  [5].  Left  atrial  volume  was  obtained
using  the  biplane  area  length  method  from  apical  four-
chamber  and  two-chamber  views  and  was  indexed  to  body
surface  area.  LVEF  was  measured  using  the  biapical  Simp-
son  method.  Left  ventricular  diastolic  function  was  assessed
by  E-wave  and  A-wave  velocities,  the  deceleration  time  of
the  E-wave,  and  the  E/A  ratio  from  the  mitral  inﬂow.  Aor-
tic  valve  area  was  calculated  using  the  continuity  equation
and  was  indexed  for  the  body  surface  area.  Pulsed-wave  tis-
sue  Doppler  imaging  velocities  were  assessed  at  the  basal
segments  of  each  of  the  two  longitudinal  planes  in  apical
four-chamber  and  two-chamber  views.  Peak  systolic  (s’),
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arly  (e’)  and  late  (a’)  diastolic  tissue  Doppler  annular  veloc-
ties  were  averaged  and  the  E/e’  ratio  was  calculated.
eft ventricular longitudinal strain study
eft  ventricular  longitudinal  strain  quantiﬁcation  was  per-
ormed  using  commercially  available  software  (EchoPAC,
ersions  BT06  and  BT08;  GE  Healthcare,  Norway).  Standard
wo-dimensional  grey-scale  loops  of  the  left  ventricle  were
cquired  in  conventional  apical  four-chamber,  two-chamber
nd  long-axis  views.  Data  were  stored  digitally  and  trans-
erred  for  off-line  analysis.  Special  care  was  taken  to  ensure
rame  rates  of  between  50  and  90  frames  per  second  in
ll  patients.  The  regions  of  interest  were  deﬁned  manually
y  marking  the  endocardial  border.  The  automatic  track-
ng  of  the  endocardial  contour  was  veriﬁed  carefully  and
he  region  of  interest  was  corrected  manually  to  ensure
ptimal  tracking  of  the  entire  myocardial  wall.  Segmental
train  analysis  was  performed  by  dividing  each  left  ventricu-
ar  image  into  six  segments.  Peak  systolic  longitudinal  strain
as  calculated  by  averaging  the  peak  systolic  values  of  the
8  segments,  derived  from  the  three  apical  views.  Repro-
ucibility  in  the  GLS  measurement  was  0.57  ±  0.77%  in  a
revious  study  by  our  group  [3].  In  our  study,  94%  (983/1044)
f  the  myocardial  segments  were  adequately  tracked.
tatistical analysis
ontinuous  variables  were  tested  for  normal  distribution
y  the  use  of  the  Kolmogorov—Smirnov  test.  Variables  not
ormally  distributed  were  expressed  as  medians  (interquar-
ile  ranges).  Normally  distributed  continuous  variables  were
xpressed  as  mean  values  ±  1  standard  deviation.  Categor-
cal  variables  were  summarized  as  frequency  percentages
nd  absolute  numbers.  The  comparison  of  continuous  varia-
les  between  patients  with  and  without  POAF  was  carried
ut  by  use  of  the  Mann—Whitney  U  test.  Frequencies  of
ategorical  variables  were  compared  with  the  2 test  or
isher’s  exact  test,  as  appropriate.  Receiver  operating  char-
cteristic  (ROC)  curve  analysis  was  used  to  identify  the  best
ut-off  values  for  GLS  for  predicting  POAF.  An  epidemiolog-
cal  approach  was  taken.  Factors  thought  to  be  important
or  the  endpoint  and  variables  signiﬁcantly  different  on  uni-
ariate  analysis  with  a  P  value  <  0.10  were  entered  into  the
ultivariable  analyses  (logistic  regression  analyses).  These
ariables  were:  age,  sex,  body  mass  index,  preoperative
F,  hypertension,  diabetes,  chronic  obstructive  pulmonary
isease  (COPD),  multivessel  coronary  disease,  preoperative
tatin  treatment,  indexed  left  atrial  volume  >  30  mL/m2,
VEF  >  50%,  aortic  valve  area  <  0.7  cm2 and  GLS  >  —15%.
odel  discrimination  was  assessed  with  ROC  analysis  by  com-
uting  the  area  under  the  ROC  curve  (AUC).  Calibration  of
he  model  was  tested  with  the  Hosmer—Lemeshow  test.
verall  model  performance  was  also  assessed  with  the  like-
ihood  ratio,  which  indicates  the  degree  to  which  the  pretest
robability  of  an  event  is  altered  by  information  provided  by
 predictive  model.  The  higher  the  model  likelihood  ratio,
he  greater  the  probability  of  accurately  predicting  events. two-sided  P  value  <  0.05  was  considered  statistically  sig-
iﬁcant.  Statistical  analysis  was  performed  using  SPSS  13.0
tatistical  software  (SPSS  Inc.,  Chicago,  IL,  USA)  and  STATA
version  10;  StataCorp  LP,  College  Station,  TX,  USA).
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tudy population
aseline  data  from  the  58  study  patients,  overall  and
ccording  to  the  occurrence  of  POAF,  are  presented  in
ables  1  and  2.  All  58  patients  had  severe  symptomatic  aortic
tenosis  (mean  aortic  valve  area  of  0.70  ±  0.17  cm2; range
.3—1  cm2).  None  of  the  patients  had  a  mean  transvalvular
radient  <  30  mmHg.  Mean  LVEF  was  60  ±  11%,  range  30  to
3%.  LVEF  was  ≤  50%  in  only  six  (10%)  patients.  Symptoms
ere  dyspnoea  in  88%  (51/58),  angina  in  43%  (25/58)  and
yncope  in  14%  (8/58).  Mean  preoperative  New  York  Heart
ssociation  class  was  2.1  ±  0.6.  Signiﬁcant  coronary  artery
isease  was  found  in  22  (38%)  patients.  Before  surgery,  19
33%)  patients  had  beta-blocker  therapy,  four  (7%)  patients
ad  amiodarone  therapy  and  36  (62%)  received  a  statin.  Bio-
rostheses  were  implanted  in  49/58  (84.5%)  and  mechanical
rostheses  in  9/58  (15.5%).  Concomitant  coronary  artery
ypass  graft  (CABG)  was  performed  in  10  patients  (17%).
erioperative  mortality  was  1/58  (1.7%);  this  patient  died  of
espiratory  failure  on  the  23rd  postoperative  day.  Signiﬁcant
ericardial  effusion  needing  surgical  treatment  was  found  in
ve  patients  (9%)  and  pulmonary  infection  in  seven  patients
12%).
p
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Table  1  Baseline  clinical  characteristics  of  the  study  populatio
atrial  ﬁbrillation.
Variable  Overall  popula
(n  =  58)  
Age  (years)  73  ±  9  
Age  ≥  80  years  17  (29)  
Men  (n;  %)  30  (52)  
Height  (cm)  166  ±  12  
Weight  (kg)  76  ±  16  
Body  mass  index  28  ±  5  
Body  surface  area  (kg/m2)  1.83  ±  0.22  
Preoperative  paroxysmal  atrial  ﬁbrillation  10  (17)  
Amiodarone  treatment  4  (7)  
Beta-blocker  treatment  19  (33)  
Statin  treatment  36  (62)  
ACE  inhibitor  treatment 27  (47)  
Hypertension 41  (71)
Diabetes  mellitus 17  (29)
Dyslipidaemia  33  (57)  
Multivessel  coronary  artery  disease  22  (38)  
Chronic  obstructive  pulmonary  disease  9  (15)  
Associated  coronary  artery  bypass  graft  10  (17)  
Cardiopulmonary  bypass  time  (minutes)  79  ±  29  
Cross-clamp  time  (minutes)  57  ±  21  
Aortic  prosthesis  type
Mechanical  9  (15.5)  
Bioprosthesis  49  (84.5)  
Postoperative  troponin  peak  7  ±  5  
Aortic  prosthesis  size  (mm)  22  ±  2  
Data are mean ± standard deviation or number (%). ACE: angiotensin-c
a For No vs. Yes.F.  Levy  et  al.
eft ventricular longitudinal strain study
lobal  and  regional  results  from  speckle  tracking  left  ven-
ricular  longitudinal  deformation  are  presented  in  Fig.  1  and
able  3.
ostoperative atrial ﬁbrillation
he  incidence  of  POAF  was  48%  (28/58).  POAF  was  persis-
ent  in  43%  of  cases  (12/28)  and  tended  to  increase  with
ge,  as  65%  of  patients  aged  >  80  years  (11/17)  developed
OAF.  History  of  paroxysmal  AF  was  reported  in  10  (17%)
atients  and  70%  of  these  patients  (7/10)  had  recurrence  of
F  after  surgery.  Sex,  hypertension,  obesity,  preoperative
eta-blocker,  amiodarone  or  angiotensin-converting  enzyme
nhibitor  treatments,  type  or  size  of  prosthesis,  cardiopul-
onary  bypass  time,  concomitant  CABG,  left  ventricular
hickness  and  left  atrial  volume  did  not  turn  out  to  be  pre-
ictors  of  POAF.  On  univariate  analysis  (Tables  1,  2  and  3),
ortic  valve  area  (P  =  0.04),  E/e’  ratio  (P  =  0.04)  and  GLS
P  =  0.005)  were  the  only  predictors  of  POAF.  COPD  (P  =  0.05),
reoperative  statin  treatment  (P  =  0.09),  age  ≥  80  years
P  =  0.09),  LVEF  (P  =  0.09),  systolic  pulmonary  artery  pres-
ure  (P  =  0.06)  tended  to  increase  the  risk  of  POAF.  E/e’  and
ystolic  pulmonary  artery  pressure  were  strongly  correlated
n  overall  and  according  to  the  occurrence  of  postoperative
tion  Postoperative  atrial  ﬁbrillation  Pa
No Yes
(n  =  30;  52%)  (n  =  28;  48%)
72  ±  9  74  ±  9  0.32
6  (20)  11  (39)  0.09
17  (57)  13  (46)  0.60
166  ±  12  165  ±  12  0.74
75  ±  18  77  ±  14  0.77
27  ±  5  28  ±  5  0.40
1.83  ±  0.25  1.82  ±  0.18  0.85
3  (10)  7  (25)  0.13
2  (7)  2  (7)  0.94
10  (33)  9  (32)  0.92
22  (73)  14  (50)  0.09
15  (50)  12  (43)  0.61
21  (70)  20  (71)  0.90
8  (27) 9  (32)  0.77
16  (53)  17  (61)  0.60
14  (47)  8  (28)  0.22
2  (7)  7  (25)  0.05
7  (23)  3  (11)  0.30
81  ±  28  77  ±  30  0.57
59  ±  23  54  ±  20  0.43
5  (17)  4  (14)  0.80
25  (83)  24  (86)
7  ±  6  8  ±  5  0.62
22  ±  2  23  ±  2  0.28
onverting enzyme.
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Table  2  Baseline  echocardiography  characteristics  of  the  study  population  overall  and  according  to  the  occurrence  of
postoperative  atrial  ﬁbrillation.
Variable  Overall  population  Postoperative  atrial  ﬁbrillation  Pa
No  Yes
(n  =  58)  (n  =  30)  (n  =  28)
LV  end-diastolic  diameter  (mm)  48  ±  7  49  ±  7  47  ±  8  0.43
LV  end-systolic  diameter  (mm)  32  ±  7  32  ±  5  32  ±  9  0.84
Indexed  LV  mass  (g/m2)  136  ±  46  127  ±  40  135  ±  52  0.53
LVEF  (%)  60  ±  11  62  ±  8  57  ±  14  0.09
LVEF  >  50%  (n;  %)  52  (90)  29  (97)  23  (82)  0.09
Posterior  wall  thickness  (mm) 12  ±  2  11±  2  12  ±  2  0.30
Aortic  valve  area  (cm2)  0.70  ±  0.17 0.74  ±  0,17  0.65  ±  0.16  0.04
Aortic  valve  area  <  0.7cm2 27  (46)  10  (33)  17  (61)  0.03
Indexed  aortic  valve  area  (cm2/m2)  0.38  ±  0.09  0.41  ±  0.09  0.36  ±  0.08  0.05
Mean  transvalvular  gradient  (mmHg)  51  ±  14  52  ±  15  50  ±  12  0.58
Left  atrial  area  (cm2)  23  ±  5  23  ±  5  22  ±  5  0.60
Left  atrial  volume  (mL) 66  ±  24  66  ±  24  65  ±  24  0.85
Indexed  left  atrial  volume  (mL/m2)  36  ±  12 36 ±  11  36  ±  13  0.88
Indexed  left  atrial  volume  >  30  mL/m2 (n;  %)  35  (60)  19  (63)  16  (57)  0.79
E  (cm/s) 81  ±  28 77 ±  26  85  ±  29  0.28
A  (cm/s) 94  ±  31 95 ±  27 93  ±  37  0.85
E-wave  deceleration  time  (ms) 267  ±  112 266  ±  103  267  ±  123  0.94
E/A  ratio 1.04  ±  0.79 0.86  ±  0.31 1.23  ±  1.07  0.08
E’  (cm/s) 6  ±  2 6 ±  2 5  ±  2 0.07
E/e’  ratio 16  ±  7 14 ±  4 18  ±  7  0.04
E/e’  ratio  >  15  (n;  %) 15 (26) 4  (13) 11  (39) 0.04
Systolic  pulmonary  artery  pressure  (mmHg) 35  ±  15 32 ±  11 41  ±  19 0.06
Data are mean ± standard deviation or number (%). LV: left ventricular; LVEF: left ventricular ejection fraction.
a For No vs. Yes.
Figure 1. Results from global and regional left ventricular longitudinal deformation in apical four-chamber (AP4C), two-chamber (AP2C)
perat
iand long-axis (AP3C) views, according to the occurrence of posto
ﬁbrillation group; **: atrial ﬁbrillation group.
(r  =  0.56,  P  =  0.0001).  The  predictive  value  of  an  impaired
GLS  (P  =  0.02)  remained  signiﬁcant  in  the  subgroup  of  52
patients  with  LVEF  >  50%.  ROC  curve  analysis  identiﬁed  a  GLS
value  of  —15%  as  the  best  cut-off  for  the  prediction  of  POAF
(82%  sensitivity,  53%  speciﬁcity,  AUC  0.72)  (Fig.  2).
i
t
aive atrial ﬁbrillation. GLS: global longitudinal strain; *: no-atrial
Results  of  the  multivariable  logistic  regression  that
ncluded  preoperative  clinical  data  (age,  sex,  body  mass
ndex,  preoperative  AF,  hypertension,  diabetes,  COPD,  mul-
ivessel  coronary  disease  and  preoperative  statin  treatment)
re  presented  in  Table  4  (Model  1).  To  further  elucidate  the
504  F.  Levy  et  al.
Table  3  Baseline  left  ventricular  strain  characteristics  of  the  study  population  overall  and  according  to  the  occurrence
of  postoperative  atrial  ﬁbrillation.
Variable  Overall  population  Postoperative  atrial  ﬁbrillation  Pa
No  Yes
(n  =  58)  (n  =  30)  (n  =  28)
LV  global  longitudinal  strain  (%) —14.2  ±  3.3  —15.5  ±  2.5  —13.0  ±  3.6  0.005
LV  global  longitudinal  strain  >  —15%  (n;  %)  28  (48)  10  (30)  18  (64)  0.03
LV  mean  longitudinal  strain  in  apical  four-chamber  view  (%)  —14.4  ±  4.0  —15.6  ±  3.4  —13.2  ±  4.3  0.02
LV  mean  longitudinal  strain  in  apical  two-chamber  view  (%)  —14.3  ±  3.6  —15.6  ±  3.1  —13.0  ±  3.6  0.005
LV  mean  longitudinal  strain  in  apical  three-chamber  view  (%)  —13.7  ±  3.6  —14.8  ±  3.0  —12.6  ±  3.9  0.02
Mean  longitudinal  strain  in  the  six  basal  LV  segments  (%)  —11.6±  4.0  —12.9  ±  3.5  —10.3  ±  9.2  0.02
Mean  longitudinal  strain  in  the  six  mid  LV  segments  (%) —13.7 ±  3.4  —154.7  ±  2.8  —12.6  ±  3.7  0.03
Mean  longitudinal  strain  in  the  six  apical  LV  segments  (%) —17.3  ±  5.7  —19.2  ±  5.2  —15.3  ±  5.7  0.01
Data are mean ± standard deviation or number (%). LV: left ventricular.
a For No vs. Yes.
Table  4  Multivariable  logistic  regression  models  for  the  prediction  of  postoperative  atrial  ﬁbrillation:  independent
predictive  factors  and  model  performance.
OR  [95%  CI]  P  Log  likelihood  AUC  [95%  CI]  Hosmer—
Lemeshow
statistic
Hosmer—
Lemeshow
P
Model  1  —64.28  0.73  [0.60—0.86]  6.06  0.53
COPD  (yes  or  no)  8.98  [0.83—96.44]  0.07
Model  2  —56.28  0.82  [0.71—0.93]  4.59  0.71
E/e’  >  15  4.20  [0.84—21.08]  0.08
Model  3  —51.28  0.86  [0.76—0.96]  10.65  0.15
GLS  >  —15%  7.74  [1.15—52.03]  0.035
AUC: area under the receiver operating characteristic curve; CI: conﬁdence interval; COPD: chronic obstructive pulmonary disease;
GLS: global longitudinal strain; OR: odds ratio. Model 1 was adjusted for age, sex, body mass index, preoperative atrial ﬁbrillation,
hypertension, diabetes, COPD, multivessel coronary disease and preoperative statin treatment. Model 2 included indexed left atrial
volume > 30 mL/m2, left ventricular ejection fraction > 50%, E/e’ > 15 and aortic valve area < 0.7 cm2 on top of the variables in Model 1.
Model 3 included GLS > —15% on top of the variables in Model 2.
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7ncremental  value  of  echocardiography  variables  in  predict-
ng  POAF,  we  added  indexed  left  atrial  volume  >  30  mL/m2,
VEF  >  50%,  E/e’  >  15  and  aortic  valve  area  <  0.7  cm2 in  a  mul-
ivariable  logistic  model  (Model  2)  on  top  of  the  variables  in
odel  1.  In  Model  2,  E/e’  tended  towards  statistical  sig-
iﬁcance  (P  =  0.08).  Finally,  when  added  to  Model  2,  left
entricular  GLS  >  —15%  was  signiﬁcantly  associated  with  a
igher  risk  of  POAF  (odds  ratio  7.74,  95%  conﬁdence  interval
.15—52.03;  P  =  0.035)  (Model  3,  Table  4).  Calibration  was
ood  for  Models  2  and  3,  as  shown  in  Table  4.  The  AUC  (C
tatistic)  of  Model  3  (0.86)  exceeded  that  of  Model  1  (0.73)
nd  Model  2  (0.81).
iscussion
o  the  best  of  our  knowledge,  this  multicentre  study  reports
or  the  ﬁrst  time  that  a  reduced  preoperative  left  ven-
ricular  myocardial  longitudinal  deformation  assessed  by
wo-dimensional  GLS  increases  the  risk  of  POAF  after  AVR
n  aortic  stenosis,  independently  of  age  and  left  atrial  size.
q
M
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AAF  is  a  frequent  complication  after  cardiac  surgery,
ith  an  incidence  ranging  between  33%  and  49%  [1,6,7].
F  occurs  more  frequently  after  cardiac  surgery  compared
ith  non-cardiac  surgery  [1].  Although  POAF  was  classi-
ally  considered  as  benign  and  without  serious  consequences
8,9], recent  data  showed  that  POAF  might  have  pejora-
ive  prognostic  implications.  Indeed,  POAF  is  associated  with
ncreased  early  and  late  mortality  after  cardiac  surgery
1,10—12],  more  frequent  embolic  events  [1,10], respiratory
nd  heart  failure,  haemorrhagic  complications  and  pro-
onged  hospital  stay  [1,11]. The  frequency  of  POAF  after
ombined  valvular  and  coronary  surgery  is  even  higher
between  36%  and  63%)  [1,13]. In  our  series,  the  incidence
f  POAF  after  AVR  increased  with  age  and  was  higher  than  in
 previous  report  by  Orlowska-Baranowska  et  al.  [6]  (48%  vs.
8%),  probably  because  our  population  was  older  (mean  age
3  ±  9  vs.  58  ±  10  years).  Accordingly,  age  is  one  of  most  fre-
uently  described  factor  predisposing  to  POAF  [1,6,7,13,14].
athew  et  al.  [11]  described  that  every  10-year  increase  is
ssociated  with  a  75%  increase  in  the  odds  of  developing
F.  In  our  series  of  severe  aortic  stenosis,  65%  of  patients
Prediction  of  postoperative  AF  after  aortic  valve  replacement  
Figure 2. Receiver operating characteristic (ROC) curve of left
ventricular global longitudinal strain to predict the occurrence of
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and  echocardiographic  variables  for  the  prediction  of  POAFpostoperative atrial ﬁbrillation.
aged  >  80  years  had  POAF.  Rostagno  et  al.  [7]  described  a  30%
higher  probability  of  POAF  in  patients  aged  >  80  years  than
in  patients  aged  70  to  80  years.  Age-related  changes  in  the
structure  of  the  heart  (left  ventricular  hypertrophy,  atrial
dilation  and  increased  ﬁbrosis)  in  conjunction  with  a post-
operative  inﬂammatory  response  may  explain  this  increased
risk  [7].  Additionally,  in  previous  studies  [6,7,14,15], preop-
erative  AF  episodes  were  associated  with  POAF.  The  impact
of  left  atrial  enlargement  on  POAF  remains  controversial
after  AVR,  although  it  has  been  demonstrated  after  CABG
[16—18].  Our  study,  as  in  other  previous  reports  [6,11,16],
failed  to  correlate  left  atrial  size  and  POAF,  suggesting  that
left  atrial  dysfunction  is  independent  of  left  atrial  remod-
elling.  Indeed,  although  left  atrial  size  increases  with  aortic
stenosis  severity  and  reﬂects  chronic  elevated  left  ventri-
cular  ﬁlling  pressures  [19]. O’Connor  et  al.  [20]  recently
demonstrated  that  a  reduction  in  tissue  Doppler-derived  left
atrial  strain  did  not  parallel  left  atrial  enlargement  in  severe
aortic  stenosis.  In  our  series,  tissue  Doppler  peak  a’  velocity
was  reduced  but  failed  to  predict  POAF.  As  suggested  [20],
as  peak  a’  velocity  is  highly  load  dependent,  global  tissue
Doppler-derived  left  atrial  strain  should  be  preferred  for
assessing  left  atrial  function.  In  our  series,  elevated  E/e’
ratio,  indicating  elevated  left  ventricular  ﬁlling  pressure,
increased  the  risk  of  POAF.  Indeed,  chronic  elevated  ﬁll-
ing  pressures  increase  left  atrial  myocyte  stretch,  leading
to  increased  atrial  effective  refractory  period  dispersion,
resulting  in  vulnerability  to  AF  [21]. As  in  previous  studies
[11,17],  COPD  patients  were  at  higher  risk  of  developing
both  paroxysmal  and  persistent  POAF.  COPD  was  reported
to  produce  a  43%  increase  in  the  odds  of  developing  AF  after
CABG  [11]. Nevertheless,  pathophysiology  remains  unclear,
probably  related  to  increased  P-wave  dispersion  in  patients
i
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ith  COPD  [22]. Risk  of  POAF  increased  with  the  severity  of
he  aortic  stenosis,  reﬂecting  a  longstanding  disease  [14].
ur  results  show  a  trend  toward  reduction  of  occurrence
f  POAF  in  patients  under  preoperative  statin  treatment.
hese  results  are  concordant  with  several  studies  [23,24]
fter  CABG  surgery  but  the  beneﬁt  of  statin  therapy  remains
nclear.  Our  main  result  is  the  increased  risk  of  POAF  in
atients  with  impaired  left  ventricular  longitudinal  myocar-
ial  strain.  Indeed,  in  severe  aortic  stenosis,  chronic  left
entricular  pressure  overload  induces  left  ventricular  hyper-
rophy,  which  maintains  adequate  wall  stress  and  preserves
 normal  LVEF.  Recent  data  suggest  that  abnormalities  in
lobal  myocardial  deformation,  particularly  in  the  longi-
udinal  contraction,  despite  a  normal  LVEF  [2,3], increase
ith  the  severity  of  aortic  stenosis  [25,26]. This  impairment
lso  correlates  with  increasing  left  ventricular  preload  (as
ssessed  by  E/e’  ratio)  [24]. As  previously  described  [25], we
ound  a  markedly  reduced  longitudinal  deformation  in  the
asal  left  ventricular  segments.  Thus,  left  ventricular  hyper-
rophy  induces  both  systolic  and  diastolic  dysfunction  and
rogressive  left  atrial  dilatation,  which  predispose  to  AF.  As
he  atria  are  attached  to  the  mediastinum  in  the  area  of  the
ulmonary  veins,  atrial  expansion  and  contraction  are  highly
nﬂuenced  by  atrioventricular  motion,  and,  thus,  by  ventri-
ular  longitudinal  contraction  and  relaxation.  As  a  result,
here  is  degree  of  reciprocity  in  the  deformation  of  both
tria  and  ventricles.  Therefore,  impairment  in  left  ventri-
ular  longitudinal  contraction  and  relaxation  (as  measured
y  GLS  and  e’)  reported  in  our  series  of  severe  aortic  steno-
is  may  induce  chronic  left  atrial  dysfunction,  which  favours
OAF.
imitations
he  strengths  of  this  study  are  the  prospective  and  multicen-
re  design  and  the  avoidance  of  single-centre  biases.  Some
arger  studies  used  continuous  telemetry  recordings  of  elec-
rocardiograms  during  the  entire  hospital  stay  [17]. After
ontinuous  electrocardiogram  monitoring  in  the  intensive
are  unit,  daily  electrocardiograms  were  used,  as  in  previous
tudies,  with  the  limitation  of  missing  some  paroxysmal  AF
pisodes  [6].  Nevertheless,  such  brief  episodes  may  not  be
linically  relevant  [17]. Due  to  the  non-randomized  nature
f  the  study,  the  effect  of  preoperative  treatment  on  POAF
ight  not  be  relevant.  Left  atrial  function  was  only  assessed
y  tissue  Doppler  peak  a’  velocity,  as  left  atrial  strain  was
ot  available  in  all  patients.  Considering  the  relatively  small
ample  size,  the  results  of  this  multicentre  pilot  study  need
o  be  conﬁrmed  in  large  studies.
onclusion
ncidence  of  POAF  is  high  after  AVR  for  severe  aortic  steno-
is.  Our  results  suggest  an  additive  value  of  the  study  of
eft  ventricular  myocardial  deformation  to  classical  clinicaln  this  setting.  Indeed,  prophylactic  antiarrhythmic  therapy
ould  be  considered  in  patients  with  impaired  longitudinal
ystolic  function  before  AVR.
5D
T
c
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[06  
isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
eferences
[1] Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial ﬁbrilla-
tion after cardiac surgery: a major morbid event? Ann Surg
1997;226:501—11. p. 11—3; discussion.
[2] Delgado V, Tops LF, van Bommel RJ, et al. Strain analysis in
patients with severe aortic stenosis and preserved left ventri-
cular ejection fraction undergoing surgical valve replacement.
Eur Heart J 2009;30:3037—47.
[3] Marechaux S, Carpentier E, Six-Carpentier M, et al. Impact
of valvuloarterial impedance on left ventricular longitu-
dinal deformation in patients with aortic valve steno-
sis and preserved ejection fraction. Arch Cardiovasc Dis
2010;103:227—35.
[4] Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the manage-
ment of atrial ﬁbrillation: the task force for the management of
atrial ﬁbrillation of the European Society of Cardiology (ESC).
Eur Heart J 2010;31:2369—429.
[5] Lang RM, Bierig M, Devereux RB, et al. Recommendations for
chamber quantiﬁcation: a report from the American Society of
Echocardiography’s Guidelines and Standards Committee and
the Chamber Quantiﬁcation Writing Group, developed in con-
junction with the European Association of Echocardiography,
a branch of the European Society of Cardiology. J Am Soc
Echocardiogr 2005;18:1440—63.
[6] Orlowska-Baranowska E, Baranowski R, Michalek P, et al. Pre-
diction of paroxysmal atrial ﬁbrillation after aortic valve
replacement in patients with aortic stenosis: identiﬁca-
tion of potential risk factors. J Heart Valve Dis 2003;12:
136—41.
[7] Rostagno C, La Meir M, Gelsomino S, et al. Atrial ﬁbrillation
after cardiac surgery: incidence, risk factors, and economic
burden. J Cardiothorac Vasc Anesth 2010;24:952—8.
[8] Fuller JA, Adams GG, Buxton B. Atrial ﬁbrillation after coronary
artery bypass grafting. Is it a disorder of the elderly? J Thorac
Cardiovasc Surg 1989;97:821—5.
[9] Lauer MS, Eagle KA, Buckley MJ, et al. Atrial ﬁbrillation fol-
lowing coronary artery bypass surgery. Prog Cardiovasc Dis
1989;31:367—78.
10] Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial ﬁbril-
lation after coronary artery surgery. Current trends and impact
on hospital resources. Circulation 1996;94:390—7.
11] Mathew JP, Fontes ML, Tudor IC, et al. A multicenter
risk index for atrial ﬁbrillation after cardiac surgery. JAMA
2004;291:1720—9.
[F.  Levy  et  al.
12] Stamou SC, Dangas G, Hill PC, et al. Atrial ﬁbrillation after
beating heart surgery. Am J Cardiol 2000;86:64—7.
13] Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards
of postoperative atrial arrhythmias. Ann Thorac Surg
1993;56:539—49.
14] Banach M, Goch A, Misztal M, et al. Predictors of paroxysmal
atrial ﬁbrillation in patients undergoing aortic valve replace-
ment. J Thorac Cardiovasc Surg 2007;134:1569—76.
15] Mathew JP, Parks R, Savino JS, et al. Atrial ﬁbrillation follow-
ing coronary artery bypass graft surgery: predictors, outcomes,
and resource utilization. MultiCenter Study of Perioperative
Ischemia Research Group. JAMA 1996;276:300—6.
16] Benedetto U, Melina G, Roscitano A, et al. Clinical utility
of tissue Doppler imaging in prediction of atrial ﬁbrilla-
tion after coronary artery bypass grafting. Ann Thorac Surg
2007;83:83—8.
17] Osranek M, Fatema K, Qaddoura F, et al. Left atrial volume
predicts the risk of atrial ﬁbrillation after cardiac surgery: a
prospective study. J Am Coll Cardiol 2006;48:779—86.
18] Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic
dysfunction as a predictor of the ﬁrst diagnosed nonvalvular
atrial ﬁbrillation in 840 elderly men and women. J Am Coll
Cardiol 2002;40:1636—44.
19] Lancellotti P, Karsera D, Tumminello G, et al. Determi-
nants of an abnormal response to exercise in patients with
asymptomatic valvular aortic stenosis. Eur J Echocardiogr
2008;9:338—43.
20] O’Connor K, Magne J, Rosca M, et al. Left atrial func-
tion and remodelling in aortic stenosis. Eur J Echocardiogr
2011;12:299—305.
21] Jais P, Peng JT, Shah DC, et al. Left ventricular diastolic dys-
function in patients with so-called lone atrial ﬁbrillation. J
Cardiovasc Electrophysiol 2000;11:623—5.
22] Tukek T, Yildiz P, Akkaya V, et al. Factors associated with
the development of atrial ﬁbrillation in COPD patients: the
role of P-wave dispersion. Ann Noninvasive Electrocardiol
2002;7:222—7.
23] Fauchier L, Pierre B, de Labriolle A, et al. Antiarrhythmic effect
of statin therapy and atrial ﬁbrillation a meta-analysis of ran-
domized controlled trials. J Am Coll Cardiol 2008;51:828—35.
24] Patti G, Chello M, Candura D, et al. Randomized trial of ator-
vastatin for reduction of postoperative atrial ﬁbrillation in
patients undergoing cardiac surgery: results of the ARMYDA-
3 (atorvastatin for reduction of myocardial dysrhythmia after
cardiac surgery) study. Circulation 2006;114:1455—61.
25] Cramariuc D, Gerdts E, Davidsen ES, et al. Myocardial defor-
mation in aortic valve stenosis: relation to left ventricular
geometry. Heart 2010;96:106—12.26] Arnold C, Delgado V, Bertini M, et al. Alterations in multidi-
rectional myocardial functions in patients with aortic stenosis
and preserved ejection fraction: a two-dimensional speckle
tracking analysis. Eur Heart J 2011;32:1542—50.
